Balaxi Pharmaceuticals Ltd Financials Statements

Annual and Quarterly P/L, Balance Sheet, Cash Flow & Financial Ratios

Consolidate
Standalone
Financial Year
Dec '24
Sep '24
Jun '24
Mar '24
Dec '23
Total Qtr Revenue cr
77.23
73.27
63.77
58.05
60.65
Other Income Qtr Cr3.94-4.11-1.85-1.79-0.13
Operating Revenues Qtr73.2977.3865.6259.8360.78

*All values are in Cr.

Operating Expenses Qtr
69.30
66.79
55.54
46.37
47.13
Operating Profit Qtr
3.99
10.59
10.09
13.47
13.66
EBIDT Qtr Cr
7.93
6.48
8.24
12.77
15.17
Depreciation Qtr
0.48
0.46
0.49
0.67
0.48
Net Profit Qtr
5.36
4.59
6.48
10.93
13.59
Basic EPS Qtr
0.97
0.84
1.17
10.41
13.29
Open Demat Account
+91 -

personImage
Open Demat Account
+91 -